CH636449A5 - Verfahren zur gewinnung eines neuen, spezifischen alpha-l-antikoerpers. - Google Patents

Verfahren zur gewinnung eines neuen, spezifischen alpha-l-antikoerpers. Download PDF

Info

Publication number
CH636449A5
CH636449A5 CH422777A CH422777A CH636449A5 CH 636449 A5 CH636449 A5 CH 636449A5 CH 422777 A CH422777 A CH 422777A CH 422777 A CH422777 A CH 422777A CH 636449 A5 CH636449 A5 CH 636449A5
Authority
CH
Switzerland
Prior art keywords
antigen
solution
antibody
determination
added
Prior art date
Application number
CH422777A
Other languages
German (de)
English (en)
Inventor
Jun-Ichi Tohmatsu
Tomiaki Morimoto
Emiko Kishi
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3792876A external-priority patent/JPS6026181B2/ja
Priority claimed from JP3793076A external-priority patent/JPS52128213A/ja
Priority claimed from JP3793176A external-priority patent/JPS52128214A/ja
Priority claimed from JP3792976A external-priority patent/JPS52128212A/ja
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of CH636449A5 publication Critical patent/CH636449A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CH422777A 1976-04-05 1977-04-04 Verfahren zur gewinnung eines neuen, spezifischen alpha-l-antikoerpers. CH636449A5 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP3792876A JPS6026181B2 (ja) 1976-04-05 1976-04-05 α−Ｌ抗体の製造法
JP3793076A JPS52128213A (en) 1976-04-05 1976-04-05 Reagents for detecting alpha-l-antibody and alpha-l-antigen
JP3793176A JPS52128214A (en) 1976-04-05 1976-04-05 Purification of alpha-l-antigen
JP3792976A JPS52128212A (en) 1976-04-05 1976-04-05 Reagents for detecting alpha-l-antigen and alpha-l-antibody

Publications (1)

Publication Number Publication Date
CH636449A5 true CH636449A5 (de) 1983-05-31

Family

ID=27460496

Family Applications (1)

Application Number Title Priority Date Filing Date
CH422777A CH636449A5 (de) 1976-04-05 1977-04-04 Verfahren zur gewinnung eines neuen, spezifischen alpha-l-antikoerpers.

Country Status (6)

Country Link
US (1) US4132767A (US20060016700A1-20060126-C00001.png)
CH (1) CH636449A5 (US20060016700A1-20060126-C00001.png)
DE (1) DE2714751A1 (US20060016700A1-20060126-C00001.png)
FR (1) FR2347688A1 (US20060016700A1-20060126-C00001.png)
GB (1) GB1564063A (US20060016700A1-20060126-C00001.png)
SE (2) SE446128B (US20060016700A1-20060126-C00001.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232001A (en) * 1978-09-22 1980-11-04 University Patents, Inc. Methods and materials for detection of estrophilin
US4241044A (en) * 1978-12-28 1980-12-23 Abbott Laboratories Method of diagnosing cancer by detecting elevated anti-T antibody activity
DK36980A (da) * 1979-01-30 1980-07-31 Otsuka Pharma Co Ltd Fremgangsmaade til bestemmelse af tumorforbundet glycobindingsholdigt stof og diagnosticering af cancer
GB2161165A (en) * 1984-06-12 1986-01-08 Cambridge Patent Dev Secondary antibodies
US5134662A (en) * 1985-11-04 1992-07-28 Cell Analysis Systems, Inc. Dual color camera microscope and methodology for cell staining and analysis
US5109429A (en) * 1985-11-04 1992-04-28 Cell Analysis Systems,Inc. Apparatus and method for analyses of biological specimens
US4998284A (en) * 1987-11-17 1991-03-05 Cell Analysis Systems, Inc. Dual color camera microscope and methodology for cell staining and analysis
US5086476A (en) * 1985-11-04 1992-02-04 Cell Analysis Systems, Inc. Method and apparatus for determining a proliferation index of a cell sample
US5962340A (en) * 1994-11-02 1999-10-05 Wako Pure Chemical Industries Ltd. Homogeneous immunoassay method utilizing 5-300 mM magnesium

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867363A (en) * 1970-06-01 1975-02-18 Hans John Hansen Carcinoembryonic antigens
US3697638A (en) * 1970-06-01 1972-10-10 Hoffmann La Roche Antigens
US3663684A (en) * 1970-06-01 1972-05-16 Hoffmann La Roche Carcinoembryonic antigen and diagnostic method using radioactive iodine
US3956258A (en) * 1972-05-12 1976-05-11 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US3823126A (en) * 1972-05-23 1974-07-09 K Bjorklund Process of separating human cancer antigen proteins by gel filtration
US3960827A (en) * 1972-07-10 1976-06-01 Bjoerklund K B Cancer associated polypeptide antigen, process for its preparation, process for preparing antibodies, process of cancer diagnosis and composition useful as an immunizing agent

Also Published As

Publication number Publication date
US4132767A (en) 1979-01-02
SE446128B (sv) 1986-08-11
SE8205891D0 (sv) 1982-10-18
DE2714751A1 (de) 1977-10-06
SE7703918L (sv) 1977-10-06
GB1564063A (en) 1980-04-02
SE448032B (sv) 1987-01-12
FR2347688A1 (fr) 1977-11-04
FR2347688B1 (US20060016700A1-20060126-C00001.png) 1980-12-05
DE2714751C2 (US20060016700A1-20060126-C00001.png) 1987-07-16
SE8205891L (sv) 1982-10-18

Similar Documents

Publication Publication Date Title
DE2902676C2 (de) Verfahren zur Analyse eines von RF oder C1q verschiedenen Antigens im Serum mittels eines Immunoassays
CH627187A5 (US20060016700A1-20060126-C00001.png)
EP0013930B1 (de) Immunogen, Antikörper für ein Thymus-Hormon, markiertes Thymus-Hormon und Verfahren zur Bestimmung dieses Thymushormons
DE2322562C2 (de) Verfahren zur Bestimmung von Antigenen in einer Probe
EP0001223A2 (de) Mit einer Polyhydroxyverbindung beschichteten Latex, Verfahren zur Herstellung dieses Latex, immunologisches Reagenz enthaltend diesen Latex, Verfahren zur Herstellung dieses Reagenzes, Verwendung dieses Reagenzes, Bestimmungsverfahren unter Verwendung dieses Reagenzes und Reagenziengarnitur enthaltend dieses Reagenz.
DE69001972T2 (de) Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex.
CH636449A5 (de) Verfahren zur gewinnung eines neuen, spezifischen alpha-l-antikoerpers.
DE3425186A1 (de) Humanproteine, verfahren zu deren herstellung und diese enthaltende testkits
US4299814A (en) Radioimmunoassay of MIF
EP0037963B1 (de) Neues Protein PP9, Verfahren zu seiner Gewinnung sowie seine Verwendung
DE60035267T2 (de) Verfahren zur analyse der menge an intraabdominalem fettgewebe
DE2934756C2 (de) Zusammensetzung zur Bestimmung von beta 2 -Humanmikroglobulin und Verfahren zu deren Herstellung und deren Anwendung
DE2754350A1 (de) Verfahren zur bestimmung von antikoerpern, antigenen oder komplexen aus antikoerpern und antigenen in fluessigkeiten
Lauf et al. The M-antigen in HK and LK sheep red cell membranes
EP0001812A1 (de) Verfahren zur Herstellung gereinigten Alpha-1-Fetoproteins und dessen Verwendung
DE3887727T2 (de) Partikelstabilisierte Epitope zur Standardisierung und Kontrolle von Immuntests.
DE2126128A1 (de) Medizinisches Testverfahren, Reagens und Additiv zur Durchführung des Verfahrens
EP0137345B1 (de) Membranassoziierte Proteine (MP2), Verfahren zu ihrer Gewinnung sowie ihre Verwendung
DE2733561C3 (de) Spezifisches Reagens für den Immuntest für Thymopoietin
DE2157610C3 (de) Schwangerschaftsspezifisches ß , -Glykoprotein, Verfahren zu seiner Isolierung und seine Verwendung für die Herstellung von Antiseren
EP0025508B1 (de) Verfahren zur Herstellung der dritten Komponente des Komplements aus menschlichem Blutplasma
EP0068291B1 (de) Immunochemisches Verfahren und Testkit zur Bestimmung der sauren Prostataphosphatase
Fraser et al. Proteins retained with hyaluronic acid during ultrafiltration of synovial fluid
EP0013306B1 (de) Verfahren zur Bestimmung eines opsonierenden oberflächenbindenden alpha-2-Glykoproteins
DE2062558A1 (de) Mittel zur Diagnose von primärem Leberkrebs und Verfahren zur Her stellung desselben

Legal Events

Date Code Title Description
PL Patent ceased